scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JACI.2008.09.027 |
P698 | PubMed publication ID | 18951619 |
P50 | author | Chiara Azzari | Q37839613 |
Laura Passerini | Q39508256 | ||
Eleonora Gambineri | Q43300293 | ||
Maria Grazia Roncarolo | Q56426635 | ||
Claudio Doglioni | Q56850490 | ||
P2093 | author name string | Arrigo Barabino | |
Rosa Bacchetta | |||
Wilhelm Friedrich | |||
Giuseppe Chiumello | |||
Anita Lawitschka | |||
Yves Sznajer | |||
Dragana Janic | |||
Lucia Bianchi | |||
Franco Meschi | |||
Marco Cipolli | |||
Riccardo Bonfanti | |||
Alberto Tommasini | |||
Anne Junker | |||
Lucia Perroni | |||
Desiree Dunstheimer | |||
Silvia Vignola | |||
Nadira Azzi | |||
Erick Richmond | |||
Peter H Heidemann | |||
Giantonio Cazzola | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | Q3508566 | ||
P304 | page(s) | 1105-1112.e1 | |
P577 | publication date | 2008-10-25 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity | |
P478 | volume | 122 |
Q92314206 | A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease |
Q55472404 | A case of Metaplastic atrophic gastritis in immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome. |
Q24304263 | A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells |
Q50525033 | A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. |
Q50504283 | A red baby should not be taken too lightly. |
Q36654124 | Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. |
Q34071942 | Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases |
Q37388744 | Advances in basic and clinical immunology in 2008. |
Q55495606 | Alternative Splicing of FOXP3-Virtue and Vice. |
Q27006589 | Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease |
Q37158241 | Autoantibodies in scurfy mice and IPEX patients recognize keratin 14. |
Q35046614 | Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome |
Q38558955 | Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders |
Q30251616 | Autoimmunity in primary T-cell immunodeficiencies. |
Q42700895 | Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor. |
Q40739094 | Clinical Case of Immune Dysregulation, Polyendocrinopaty, Enteropathy, X-Linked (IPEX) Syndrome with Severe Immune Deficiency and Late Onset of Endocrinopathy and Enteropathy |
Q54372229 | Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China. |
Q46321148 | Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation |
Q59137718 | Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome |
Q36756168 | Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells. |
Q35859565 | Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome. |
Q37826763 | Dendritic cells in networks of immunological tolerance. |
Q91586291 | Diagnosis and treatment of a boy with IPEX syndrome presenting with diabetes in early infancy |
Q26774590 | Disrupted regulatory T cell homeostasis in inflammatory bowel diseases |
Q38909420 | Empowering Regulatory T Cells in Autoimmunity |
Q44641781 | Endocrine complications in primary immunodeficiency diseases in Japan. |
Q26799603 | Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation |
Q33426259 | Epigenetic control of the immune system: a lesson from Kabuki syndrome |
Q27001673 | Evaluation and differential diagnosis of marked, persistent eosinophilia |
Q34778685 | Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease |
Q38172660 | Experiments by nature: lessons on type 1 diabetes. |
Q48090851 | FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum |
Q27003398 | FOXP3: genetic and epigenetic implications for autoimmunity |
Q43057292 | Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome |
Q35757391 | Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3 |
Q38172563 | Forkhead box P3: the peacekeeper of the immune system. |
Q47263216 | FoxP3 scanning mutagenesis reveals functional variegation and mild mutations with atypical autoimmune phenotypes. |
Q34515848 | From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation |
Q42745318 | Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome. |
Q88651319 | Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases |
Q37564321 | Gastrointestinal manifestations in primary immune disorders |
Q35646681 | Gene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome. |
Q38053490 | Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations |
Q43089114 | Gut immune reconstitution in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome after hematopoietic stem cell transplantation. |
Q35962333 | Human Embryonic Stem Cell Lines with Lesions in FOXP3 and NF1. |
Q24317691 | Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity |
Q33391755 | IPEX syndrome and human Treg cells |
Q48090046 | Immune Dysregulation Syndromes (IPEX, CD27 Deficiency, and Others): Always Doomed from the Start? |
Q64236146 | Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Associated With a Novel Mutation of Gene |
Q85208897 | Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and recurrent intrauterine fetal death |
Q36282394 | Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity |
Q37538526 | Immunopathogenesis of granulomas in chronic autoinflammatory diseases |
Q39312948 | Inflammatory bowel disease caused by primary immunodeficiencies-Clinical presentations, review of literature, and proposal of a rational diagnostic algorithm |
Q40348808 | Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea. |
Q45875838 | Long-term follow up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. |
Q42557833 | Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency |
Q28066193 | Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies |
Q38913100 | Monogenic autoimmune diseases of the endocrine system |
Q38849738 | Pediatric inflammatory bowel disease: specificity of very early onset |
Q64251926 | Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework |
Q26746046 | Primary immunodeficiencies associated with eosinophilia |
Q51543975 | Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. |
Q37792762 | Recognizing Gastrointestinal and Hepatic Manifestations of Primary Immunodeficiency Diseases |
Q33723867 | Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective |
Q33729446 | Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis |
Q28267935 | Regulatory T cells exert checks and balances on self tolerance and autoimmunity |
Q34574231 | Regulatory T cells in many flavors control asthma |
Q37967097 | Regulatory T cells: banned cells for decades |
Q43971473 | Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome |
Q27670827 | Structural and Biological Features of FOXP3 Dimerization Relevant to Regulatory T Cell Function |
Q90700436 | Successful Salvage Haploidentical Alpha-Beta T Cell-Depleted Stem Cell Transplantation After Busulfan-Based Myeloablation in a Patient With IPEX Syndrome: A Case Report |
Q38753362 | T Regulatory Cell Biology in Health and Disease. |
Q38035848 | The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function |
Q82681931 | [What's new in dermatological research?] |
Search more.